CHM-029

N/A

Report date: 2025/12/05 16:18:29

Base Information

Drug NameCHM-029
Drug Alias NameCHM-029CHM029
ClassificationOther
Mechanisms of ActionMenin inhibitors
TargetsMenin
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCharm Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCharm Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A